A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/18 (2006.01) A61K 31/505 (2006.01) A61K 45/06 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2749051
The present invention relates to methods for identifying patients who will respond well to cancer treatment with a therapeutic regimen that comprises the use of a histone deacetylase inhibitor (HDACi) and one or more further chemotherapeutic agents. The invention also relates to methods of treating such patients with a therapeutic regimen comprising the use of a histone deacetylase inhibitor (HDACi) and one or more further chemotherapeutic agents.
L'invention concerne des méthodes destinées à identifier des patients susceptibles de bien réagir à un traitement anticancéreux au moyen d'un régime thérapeutique consistant à utiliser un inhibiteur d'histone désacétylase (HDACi) et au moins un autre agent chimiothérapeutique. L'invention concerne également des méthodes de traitement de ces patients au moyen d'un régime thérapeutique consistant à utiliser un inhibiteur d'histone désacétylase (HDACi) et au moins un autre chimiothérapeutique.
Smart & Biggar
Topotarget A/s
LandOfFree
Methods for identifying patients who will respond well to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for identifying patients who will respond well to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying patients who will respond well to... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1650962